Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | RNA binding protein | 0.0066 | 0.0259 | 0.0259 |
Loa Loa (eye worm) | hypothetical protein | 0.06 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0066 | 0.0259 | 0.0259 |
Onchocerca volvulus | 0.0344 | 0.5325 | 0.2556 | |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.372 | 0.372 |
Loa Loa (eye worm) | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.06 | 1 | 1 |
Brugia malayi | LBP/BPI | 0.0256 | 0.372 | 0.372 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0066 | 0.0259 | 0.0259 |
Loa Loa (eye worm) | TAR-binding protein | 0.0066 | 0.0259 | 0.0259 |
Echinococcus multilocularis | tar DNA binding protein | 0.0066 | 0.0259 | 0.5 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.06 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0259 | 0.5 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0259 | 0.5 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0259 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0256 | 0.372 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.372 | 0.372 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0259 | 0.5 |
Echinococcus granulosus | tar DNA binding protein | 0.0066 | 0.0259 | 0.5 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Brugia malayi | hypothetical protein | 0.0256 | 0.372 | 0.372 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0344 | 0.5325 | 0.5325 |
Loa Loa (eye worm) | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.372 | 0.372 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0066 | 0.0259 | 0.0259 |
Onchocerca volvulus | 0.0344 | 0.5325 | 0.2556 | |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0344 | 0.5325 | 0.5325 |
Brugia malayi | RNA binding protein | 0.0066 | 0.0259 | 0.0259 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0344 | 0.5325 | 0.5325 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0256 | 0.372 | 0.372 |
Loa Loa (eye worm) | LBP/BPI/CETP family domain-containing protein | 0.0344 | 0.5325 | 0.5325 |
Brugia malayi | LBP / BPI / CETP family, N-terminal domain containing protein | 0.06 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Loa Loa (eye worm) | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Onchocerca volvulus | 0.06 | 1 | 1 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.0259 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0344 | 0.5325 | 0.5325 |
Brugia malayi | LBP / BPI / CETP family, C-terminal domain containing protein | 0.0344 | 0.5325 | 0.5325 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 100 uM | PUBCHEM_BIOASSAY: SAR analysis of Antagonists of IAP-family anti-apoptotic proteins. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1018, AID1449, AID1513, AID1514, AID1638] | ChEMBL. | No reference |
IC50 (binding) | > 100 uM | PUBCHEM_BIOASSAY: SAR analysis of Antagonists of XIAP-Bir3 domain of IAP-family anti-apoptotic proteins. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1018, AID1449, AID1513, AID1514, AID1638] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.